대한임상검사과학회지 (Korean Journal of Clinical Laboratory Science)

  • 제50권3호
  • /
  • Pages.337-344
  • /
  • 2018
  • /
  • 1738-3544(pISSN)
  • /
  • 2288-1662(eISSN)
대한임상검사과학회 (Korean Society for Clinical Laboratory Science)
권호 표지
DOI QR코드

DOI QR Code

간암세포주에서 상피간엽전환억제를 통한 Silymarin의 침윤 및 전이 억제 효과

Silymarin Attenuates Invasion and Migration through the Regulation of Epithelial-mesenchymal Transition in Huh7 Cells

  • 김도훈 (동의대학교 임상병리학과) ;
  • 박소정 (동의대학교 임상병리학과) ;
  • 이승연 (동의대학교 임상병리학과) ;
  • 윤현서 (동의대학교 치위생학과) ;
  • 박충무 (동의대학교 임상병리학과)
  • Kim, Do-Hoon (Department of Clinical Laboratory Science, Dong-Eui University) ;
  • Park, So-Jeong (Department of Clinical Laboratory Science, Dong-Eui University) ;
  • Lee, Seung-Yeon (Department of Clinical Laboratory Science, Dong-Eui University) ;
  • Yoon, Hyun-Seo (Department of Dental Hygiene, Dong-Eui University) ;
  • Park, Chung Mu (Department of Clinical Laboratory Science, Dong-Eui University)
  • 투고 : 2018.07.18
  • 심사 : 2018.08.02
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

발생하는 간암 중 가장 주요한 형태인 간세포암은 강한 전이특성으로 인해 높은 재발율과 사망률을 보인다. Silymarin은 엉겅퀴에서 추출한 플라보노이드 성분으로 여러 암세포주에서 상피간엽전환(epithelial mesenchymal transition, EMT) 조절을 통해 항암효과를 보이는 것으로 보고되었다. 본 연구에서는 silymarin이 EMT의 조절을 통해 간세포암 세포주인 Huh7 cell의 침윤과 전이를 억제하는지를 분석하고자 하였다. Huh7 cell의 침윤과 전이 활성을 분석하기 위하여 wound healing assay와 in vitro invasion assay를 시행하였고 EMT 관련 유전자와 상위 신호전달물질의 발현 분석을 위해 Western blot assay를 실시하였다. 그 결과 silymarin은 농도 의존적으로 Huh7 cell의 침윤과 전이를 억제하였다. EMT 관련 유전자 중 세포 부착 단백질인 E-cadherin은 증가하였으나, 중간엽세포의 지표인 vimentin, 종양미세환경 조절에 관여하는 MMP-9의 발현은 억제되었고 이들의 활성에 관여하는 전사인자인 Snail과 nuclear factor $(NF)-{\kappa}B$ 또한 농도 의존적으로 활성이 감소하는 것을 확인할 수 있었다. 특히, 상위신호전달물질 중 silymarin은 phosphoinositide-3-kinase (PI3K)/Akt의 인산화 억제를 통해 EMT 관련 유전자들을 조절하는 것으로 나타났고 이것은 selective inhibitor인 LY294002의 처리 결과로 확인할 수 있었다. 결과적으로, silymarin은 PI3K/Akt 경로를 통해 EMT 관련 유전자의 발현을 조절함으로써 Huh7 cell의 침윤과 전이를 억제하는 것으로 생각된다. 이를 통해 silymarin이 간세포암의 전이 억제에 효과적인 항암물질의 후보가 될 수 있는 잠재력을 가진 후보물질이 될 수 있음을 보여주었다.

Hepatocellular carcinoma (HCC), a major type of hepatoma, is associated with high recurrence and mortality because of its uncontrolled metastatic feature. Silymarin is a polyphenolic flavonoid from Silybum marianun (milk thistle) and exhibits anti-carcinogenic activity through modulation of the epithelial-mesenchymal transition (EMT) in several cancer cells. In this study, the inhibitory mechanism of silymarin against migration and invasion was investigated in the Huh7 HCC cell line. Wound healing and in vitro invasion assays were conducted to examine the effects of silymarin on migration and invasion. Western blot analysis was also applied to evaluate the inhibitory effects of silymarin on the EMT-related genes and their upstream signaling molecules. Silymarin inhibited the migratory and invasive activities of Huh7 cells. In addition, silymarin attenuated the protein expression levels of vimentin and matrix metalloproteinase (MMP)-9 as well as their transcription factors, Snail, and nuclear factor $(NF)-{\kappa}B$, while the expression of E-cadherin was increased by the silymarin treatment. Among the upstream signaling molecules, the phosphorylation of Akt was inhibited by the silymarin treatment, which was confirmed by the selective inhibitor, LY294002. Consequently, silymarin inhibited the invasive and migratory activities in Huh7 cells through the modulation of EMT-related gene expression by the PI3K/Akt signaling pathway, which may have potential as a chemopreventive agent against HCC metastasis.

키워드

참고문헌

  1. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119:1429-1437. https://doi.org/10.1172/JCI36183
  2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139:871-890. https://doi.org/10.1016/j.cell.2009.11.007
  3. van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, et al. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5:1169-1179. https://doi.org/10.2217/fon.09.91
  4. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15:178-196. https://doi.org/10.1038/nrm3758
  5. Kim SM, Han JH, Park SM. The role of epithelial-mesenchymal transition in the gastroenterology. Kor J Gastroenterol. 2010; 56:69-77. https://doi.org/10.4166/kjg.2010.56.2.69
  6. Chen PN, Hsieh YS, Chiou HL Chu SC. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact. 2005;156:141-150. https://doi.org/10.1016/j.cbi.2005.08.005
  7. Cufi S, Bonavia R, Vazquez-Martin A, Corominas-Faja B, Oliveras-Ferraros C, Cuyas E, et al. Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells. Food Chem Toxicol. 2013;60:360-368. https://doi.org/10.1016/j.fct.2013.07.063
  8. Deep G, Agarwal R. Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev. 2010;29:447-463. https://doi.org/10.1007/s10555-010-9237-0
  9. Deep G, Gangar SC, Agarwal C, Agarwal R. Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. Cancer Prev Res (Phila). 2011;4:1222-1232. https://doi.org/10.1158/1940-6207.CAPR-10-0370
  10. Skottova N, Krecman V, Simanek V. Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro. Phytother Res. 1999;13:535-537. https://doi.org/10.1002/(SICI)1099-1573(199909)13:6<535::AID-PTR526>3.0.CO;2-W
  11. Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, et al. Silibinin inhibits $\beta$-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell Signal. 2013;25:2625-2633. https://doi.org/10.1016/j.cellsig.2013.08.028
  12. Hsieh MJ, Lin CW, Yang SF, Chen MK, Chiou HL. Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-${\kappa}B$ and AP-1 activity in human liver cancer cells. Br J Pharmacol. 2014; 171:3037-3050. https://doi.org/10.1111/bph.12626
  13. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007;39: 305-318. https://doi.org/10.1080/00313020701329914
  14. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, et al. Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene. 2004;23:298-302. https://doi.org/10.1038/sj.onc.1206483
  15. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497-2507. https://doi.org/10.1158/0008-5472.CAN-06-3075
  16. National Cancer Information Center (KR). Cancer statistics. Cancer incidence in 2015 [Internet]. Goyang: National Cancer Information Center; 2015 [Cited 2018 June 04]. Available from: https://www.cancer.go.kr/lay1/S1T639C641/contents.do.
  17. National Cancer Information Center (KR). Cancer statistics. Liver cancer incidence by histology group in 2015 [Internet]. Goyang: National Cancer Information Center; 2015 [Cited 2018 June 04]. Available from: https://www.cancer.go.kr/lay1/program/S1T211C216/cancer/view.do?cancer_ seq=3317&menu_seq=3322.
  18. Tang ZY. Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol. 2001;7:445-454. https://doi.org/10.3748/wjg.v7.i4.445
  19. Lee HS, Choi GH, Hwang HK, Kang CM, Choi JS, Lee WJ. The risk factors for extrahepatic recurrence after curative resection of hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg. 2010;14:227-234.
  20. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229-235. https://doi.org/10.1097/01.sla.0000197706.21803.a1
  21. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;16:704-715.
  22. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, et al. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999;112:4615-4625.
  23. Huang C, Jacobson K, Schaller, MD. A role for jnk-paxillin signaling in cell migration. Cell Cycle. 2004;3:4-6.
  24. Huang C, Jacobson K, Schaller MD. Map kinases and cell migration. J Cell Sci. 2004;117(Pt 20):4619-4628. https://doi.org/10.1242/jcs.01481
  25. Hsieh YS, Chu SC, Yang SF, Chen PN, Liu YC, Lu KH. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Carcinogenesis. 2007;28:977-987.
  26. Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC, Lee IS. Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun. 2007; 354:165-171. https://doi.org/10.1016/j.bbrc.2006.12.181